Advertisement

Topics

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

14:00 EST 13 Nov 2017 | PhRMA

Perhaps the biggest fact that is often overlooked about Part D is that there is already significant price negotiation in the program. Thanks to Part D’s competitive structure, large purchasers often negotiate steep discounts and rebates with prescription drug manufacturers. This robust competition and negotiation consistently keeps costs low for beneficiaries and taxpayers. The Medicare Trustees report negotiated rebates have increased every year of the program and premiums have remained stable since 2011. In fact, average monthly premiums are expected to decrease in 2018.

Original Article: Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

NEXT ARTICLE

More From BioPortfolio on "Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...